Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes

Annie R. Piñeros,Abhishek Kulkarni,Hongyu Gao,Kara S. Orr,Lindsey Glenn,Fei Huang,Yunlong Liu,Maureen Gannon,Farooq Syed,Wenting Wu,Cara M. Anderson,Carmella Evans-Molina,Marcia McDuffie,Jerry L. Nadler,Margaret A. Morris,Raghavendra G. Mirmira,Sarah A. Tersey

DOI: https://doi.org/10.1016/j.celrep.2022.111011

IF: 8.8

2022-06-28

Cell Reports

Abstract:Type 1 diabetes is a disorder of immune tolerance that leads to death of insulin-producing islet β cells. We hypothesize that inflammatory signaling within β cells promotes progression of autoimmunity within the islet microenvironment. To test this hypothesis, we deleted the proinflammatory gene encoding 12/15-lipoxygenase (Alox15) in β cells of non-obese diabetic mice at a pre-diabetic time point when islet inflammation is a feature. Deletion of Alox15 leads to preservation of β cell mass, reduces populations of infiltrating T cells, and protects against spontaneous autoimmune diabetes in both sexes. Mice lacking Alox15 in β cells exhibit an increase in a population of β cells expressing the gene encoding the protein programmed death ligand 1 (PD-L1), which engages receptors on immune cells to suppress autoimmunity. Delivery of a monoclonal antibody against PD-L1 recovers the diabetes phenotype in knockout animals. Our results support the contention that inflammatory signaling in β cells promotes autoimmunity during type 1 diabetes progression.

cell biology